CV Sciences, Inc. (OTCMKTS:CVSI) Short Interest Update

CV Sciences, Inc. (OTCMKTS:CVSI) was the recipient of a significant growth in short interest during the month of October. As of October 15th, there was short interest totalling 21,700 shares, a growth of 239.1% from the September 30th total of 6,400 shares. Based on an average daily volume of 253,600 shares, the short-interest ratio is currently 0.1 days.

CV Sciences Price Performance

Shares of CVSI stock remained flat at $0.05 during trading hours on Friday. The company’s stock had a trading volume of 387,938 shares, compared to its average volume of 286,547. CV Sciences has a 52-week low of $0.03 and a 52-week high of $0.10. The company’s fifty day moving average is $0.05 and its 200 day moving average is $0.05. The firm has a market capitalization of $8.71 million, a P/E ratio of -2.40 and a beta of 0.61.

CV Sciences Company Profile

CV Sciences, Inc develops, manufactures, markets, and sells herbal supplements and hemp-based cannabidiol (CBD) in North America. It operates in two segments, Consumer Products and Specialty Pharmaceutical. The company offers its products under the PlusCBD, ProCBD, HappyLane, CVAcute, CVDefense, and PlusCBD Pet brands in the health care market sector, including nutraceutical, beauty care, specialty foods, and pet products through its websites, elect distributors, brick and mortar retailers, and select e-tailers.